Navigation Links
Unexpected signaling role for foul-smelling hydrogen sulfide in cell response to protein misfolding

Cold Spring Harbor, NY -- Something rotten never smelled so sweet.

This is what members of a team of scientists at Cold Spring Harbor Laboratory (CSHL) are telling one another as they discuss a new finding they did not expect to make. They have discovered that hydrogen sulfide (H2S) the flammable, highly toxic gas that we usually associate with the smell of rotten eggs in landfills and sewers plays an important role in the regulation of a signaling pathway implicated in biological malfunctions linked to Alzheimer's and Parkinson's diseases, among others.

"H2S comes under the category of things that people think of as toxic and nasty, but which can actually be harnessed to serve a useful purpose," says CSHL Professor Nicholas K. Tonks, FRS, who led the research team. In fact, H2S, which is produced naturally in small quantities in various tissues, is a gasotransmitter, one of a family of gaseous signaling molecules that includes nitrous oxide (NO) and carbon monoxide (CO). Unlike growth factors, cytokines and hormones that act through receptors in the cell membrane, these gasotransmitters are able to permeate membranes and enter freely the interior of living cells.

Tonks and colleagues were intrigued by reports in the scientific literature suggesting that H2S was produced as part of the cell's response to what is called ER stress. The ER is the cellular organ called the endoplasmic reticulum. It is an extensive network of membranes spread throughout the cytosol, which is involved in protein synthesis and processing.

When the cell is placed under stress, specifically when newly formed proteins are being manufactured in the ER so rapidly that they do not fold properly, rendering them non-functional, the cell must make a decision either to slow down protein production to match its physiological requirements in the hope that proteins will begin to fold properly or, if that is not sufficient, to commit a form of suicide called apoptosis.

The surprise in the research performed by Tonks' team which is published online today in Science Signaling is that H2S plays a critical role in the exquisitely tuned signaling pathway through which cells make this fateful determination.

Navasona Krishnan, a postdoctoral fellow, performed an experiment to determine whether H2S could covalently modify an enzyme called PTP1B. Discovered by Tonks in 1988, PTP1B is a protein tyrosine phosphatase, or PTP an enzyme that specifically removes phosphate groups from amino acid residues called tyrosines. This function is critical in regulating cellular signaling in normal and disease conditions.

H2S did indeed modify PTP1B, specifically on a cysteine amino acid residue in the enzyme's active site, which inactivated the enzyme. A number of subsequent experiments performed in collaboration with CSHL Professor Darryl Pappin, who directs the proteomics Shared Resource at the Laboratory, identified this modification and revealed that it occurred in vitro and in vivo.

Because PTP1B is itself a signaling pathway regulator, this inactivation was immediately understood to be important and potentially useful. Further experimentation revealed that the H2S-induced modification to PTP1B prevented this phosphatase from inactivating an enzyme called PERK, which is a sensor of the presence of unfolded proteins and a critical regulator of the cell's response to ER stress.

The completed puzzle is as follows: small amounts of hydrogen sulfide are produced when the cell senses ER stress; PTP1B undergoes a unique covalent modification at its active site in response to the H2S that is produced, which in turn prevents the phosphatase from dephosphorylating PERK thereby allowing the latter protein to play its specific regulatory role in response to the stress. Importantly, the process is fully reversible, such that this previously undiscovered pathway can act like a switch, to help fine-tune a response to stress that potentially can lead to cell death.

"We hypothesize that the controlled production of H2S could have a profound impact on how this part of the ER stress pathway the PERK 'arm' is regulated. When proteins are misfolded in response to cellular stress, the inactivation and reactivation of PTP1B appears to be one means by which the cell regulates its protein synthesis machinery and can exert tight control over whether it lives or dies, ," says Tonks.

The linkage of such regulation with human disease is a subject that bears further exploration. ER stress is causally related to the protein-folding-related pathologies seen in such illnesses as Alzheimer's and Parkinson's diseases, Tonks says. "What we are trying to do is understand the structure of PTP1B in the presence and absence of its modification by H2S to define this modification in molecular detail and understand its importance to the control of this major signaling enzyme in normal and disease states."


Contact: Peter Tarr
Cold Spring Harbor Laboratory

Related medicine news :

1. MIT researchers discover an unexpected twist in cancer metabolism
2. Unexpectedly small effects of mutations in bacteria bring new perspectives
3. Youth adapt faster than seniors to unexpected events
4. Unexpected find opens up new front in effort to stop HIV
5. Revealing the wiring that allows us to adapt to the unexpected
6. An extra 5 years of life an unexpected benefit of osteoporosis treatment
7. Unexpected new mechanism behind rheumatoid arthritis
8. Mount Sinai researcher finds unexpected temperature sensation for a light detector
9. Metabolic protein plays unexpected role in tumor cell formation and growth
10. Defective signaling pathway sheds light on cystic fibrosis
11. Arsenic exposure activates an oncogenic signaling pathway; leads to increased cancer risk
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/26/2016)... PLAINSBORO, N.J. (PRWEB) , ... June 27, 2016 , ... ... same sources, yet in many ways they remain in the eye of the beholder, ... Oncology (EBO), a publication of The American Journal of Managed Care. For the full ...
(Date:6/26/2016)... ... 26, 2016 , ... PawPaws brand pet supplements owned by Whole ... enhance the health of felines. The formula is all-natural and is made from Chinese ... PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   ... Spaulding Rehabilitation Network,s Dean Center for Tick ... Physical Medicine and Rehabilitation, MIT Hacking Medicine, University ... for Innovation, today announced the five finalists of ... for Lyme disease.  More than 100 scientists, clinicians, ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
Breaking Medicine Technology: